Panacos Pharmaceuticals, Inc.
OTC: PANC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John R. Barr
- Employees
- 41
- Headquarters
- Watertown, United States
- IPO year
- 2005
- Market cap
- $5.4K
- Website
- http://www.panacos.com
Loading PANC…
Loading profile data…Frequently asked questions about PANC
What does Panacos Pharmaceuticals, Inc. (PANC) do?
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology conce...
Where does PANC trade?
Panacos Pharmaceuticals, Inc. (PANC) trades on the Other OTC.
What sector is PANC in?
Panacos Pharmaceuticals, Inc. (PANC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Panacos Pharmaceuticals, Inc.?
John R. Barr is the chief executive officer of Panacos Pharmaceuticals, Inc. (PANC).
Where is Panacos Pharmaceuticals, Inc. headquartered?
Panacos Pharmaceuticals, Inc. is headquartered in United States.
Does PANC pay a dividend?
Panacos Pharmaceuticals, Inc. (PANC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PANC go public?
Panacos Pharmaceuticals, Inc. (PANC) completed its initial public offering in 2005.